Exabis Library
Welcome to the e-CCO Library!
DOP054: Discrepancies between patient-reported outcomes, endoscopic, and histologic appearance in ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
DOP054: High-throughput sequencing of T cell receptors from pediatric ulcerative colitis patients reveals distinct tissue-specific repertoires
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP054: Vedolizumab in combination with steroids for induction therapy in Crohn’s disease: an exploratory analysis of the GEMINI 2 and GEMINI 3 studies
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP055: Azithromycin based therapy for induction of remission in mild to moderate active paediatric Crohn’s disease: the Multicentre azithromycin for Crohn’s disease AZCRO trial
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
DOP055: Luminal application of a GATA3-specific DNAzyme ameliorates mucosal inflammation in a randomised trial with active ulcerative colitis patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP055: Results of the Fifth Scientific Workshop of the ECCO (II): clinical aspects of perianal fistulising Crohn's disease – the unmet needs
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP056: Efficacy and safety of anti-fractalkine monoclonal antibody, E6011, in patients with Crohn’s disease who had lost response to anti-TNFα agents: A multicentre, open-label, Phase 1/2 study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP056: Pathophysiology of perianal fistulising disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP056: Pharmacokinetics and exposure-response relationships of golimumab in paediatric patients with moderate-to-severe ulcerative colitis: results from a multicentre open-label study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
DOP057: ECCO-EBMT joint paper: autologous haematopoietic stem cell transplantation (AHSCT) in severe Crohn’s disease: Summary of the ECCO-EBMT joint review
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP057: Perianal pediatric Crohn's disease is associated with a distinct phenotype and greater inflammatory burden
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP057: Tailored step-up approach results in beneficial long-term disease outcome in the prospective Belgian registry of paediatric Crohn’s disease (BELCRO)
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
DOP058: Combined stem cells and anticytokine therapy contributes to a more pronounced decrease in the degree of inflammation of the intestinal mucosa in Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP058: Does biologic therapy increase the risk for fistula-associated mucinous adenocarcinoma in long standing perianal Crohn's disease?
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP058: Long-term avoidance of steroids associated with exclusive enteral nutrition as induction therapy in paediatric Crohn’s disease does not increase surgery, hospitalisations or biologics use: results of a propensity score-matched cohort analysis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
DOP059: Combined anticytokine and local mesenchymal stem cells therapy promotes longer healing of simple fistulas in patients with Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP059: Efficacy of exclusive enteral nutrition in adult active Crohn’s disease with complications or failure of medical treatment
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
DOP059: New human gut xenograft mouse model for intestinal fistulas
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP05: Adipose-derived stem cells from Crohn’s disease patients show antigen presenting cell-like properties
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP05: Morbid obesity, a new susceptibility factor for developing Inflammatory Bowel Disease. Results of a population-based study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM